Cargando…
Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy
Adoptive cell therapy (ACT) is a personalized therapy that has shown great success in treating hematologic malignancies in clinic, and has also demonstrated potential applications for solid tumors. The process of ACT involves multiple steps, including the separation of desired cells from patient tis...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145949/ https://www.ncbi.nlm.nih.gov/pubmed/37421109 http://dx.doi.org/10.3390/mi14040877 |